Cholesterol
Twice-yearly inclisiran cuts LDL in ASCVD patients
VIDEO: Pediatric cholesterol screening faces barriers to adoption
ATLANTA — In this video exclusive, Amy L. Peterson, MD, director of pediatric preventive cardiology and associate professor of pediatrics in the division of pediatric cardiology at the University of Wisconsin School of Medicine and Public Health in Madison, discusses her presentation at the FH Foundation’s FH Global Summit, which focused on her team’s research on cholesterol screening, especially in children to diagnose conditions like FH.
Underuse of cholesterol-lowering medications creates ‘missed opportunities’
Tocilizumab increases HDL, LDL cholesterol, triglycerides compared with etanercept in RA
Fasting not required for metabolic syndrome assessment
Low, variable HDL cholesterol level creates ‘additive effect’ for diabetes risk
Korean adults with a variable and overall lower HDL cholesterol level are significantly more likely to develop type 2 diabetes over 5 years when compared with adults with a higher HDL cholesterol level with less fluctuation, according to a large database analysis published in The Journal of Clinical Endocrinology & Metabolism.
Patients with atherosclerotic CVD face ‘remarkable treatment gap’
Among a cohort of more than a quarter million patients with atherosclerotic CVD in Canada, only about two-thirds were prescribed lipid-lowering therapy and of those, more than a third did not reach recommended LDL cholesterol levels, according to findings recently published in the Canadian Journal of Cardiology.
Optimal CV health at midlife reduces dementia risk
GOULD
Part of the Healio Network
Statin Topic Review
HMG-CoA reductase inhibitors, commonly referred to as statins, are the cornerstone of pharmacologic reduction of elevated low-density lipoprotein cholesterol.